BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 8875926)

  • 1. Structure of the p53 tumor suppressor bound to the ankyrin and SH3 domains of 53BP2.
    Gorina S; Pavletich NP
    Science; 1996 Nov; 274(5289):1001-5. PubMed ID: 8875926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two cellular proteins that bind to wild-type but not mutant p53.
    Iwabuchi K; Bartel PL; Li B; Marraccino R; Fields S
    Proc Natl Acad Sci U S A; 1994 Jun; 91(13):6098-102. PubMed ID: 8016121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of oncogenic mutations and DNA response elements on the binding of p53 to p53-binding protein 2 (53BP2).
    Tidow H; Veprintsev DB; Freund SM; Fersht AR
    J Biol Chem; 2006 Oct; 281(43):32526-33. PubMed ID: 16887812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of p53 activity by IkappaBalpha: evidence suggesting a common phylogeny between NF-kappaB and p53 transcription factors.
    Dreyfus DH; Nagasawa M; Gelfand EW; Ghoda LY
    BMC Immunol; 2005 Jun; 6():12. PubMed ID: 15969767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The p53-binding protein 53BP2 also interacts with Bc12 and impedes cell cycle progression at G2/M.
    Naumovski L; Cleary ML
    Mol Cell Biol; 1996 Jul; 16(7):3884-92. PubMed ID: 8668206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations.
    Cho Y; Gorina S; Jeffrey PD; Pavletich NP
    Science; 1994 Jul; 265(5170):346-55. PubMed ID: 8023157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NMR spectroscopy reveals the solution dimerization interface of p53 core domains bound to their consensus DNA.
    Klein C; Planker E; Diercks T; Kessler H; Künkele KP; Lang K; Hansen S; Schwaiger M
    J Biol Chem; 2001 Dec; 276(52):49020-7. PubMed ID: 11606582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical and structural studies of ASPP proteins reveal differential binding to p53, p63, and p73.
    Robinson RA; Lu X; Jones EY; Siebold C
    Structure; 2008 Feb; 16(2):259-68. PubMed ID: 18275817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of ASPP2 interaction with p53 core domain by an intramolecular autoinhibitory mechanism.
    Rotem-Bamberger S; Katz C; Friedler A
    PLoS One; 2013; 8(3):e58470. PubMed ID: 23472201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NF-kappaB subunit p65 binds to 53BP2 and inhibits cell death induced by 53BP2.
    Yang JP; Hori M; Takahashi N; Kawabe T; Kato H; Okamoto T
    Oncogene; 1999 Sep; 18(37):5177-86. PubMed ID: 10498867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APCL, a central nervous system-specific homologue of adenomatous polyposis coli tumor suppressor, binds to p53-binding protein 2 and translocates it to the perinucleus.
    Nakagawa H; Koyama K; Murata Y; Morito M; Akiyama T; Nakamura Y
    Cancer Res; 2000 Jan; 60(1):101-5. PubMed ID: 10646860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of a superstable mutant of human p53 core domain. Insights into the mechanism of rescuing oncogenic mutations.
    Joerger AC; Allen MD; Fersht AR
    J Biol Chem; 2004 Jan; 279(2):1291-6. PubMed ID: 14534297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis for ASPP2 recognition by the tumor suppressor p73.
    Canning P; von Delft F; Bullock AN
    J Mol Biol; 2012 Nov; 423(4):515-27. PubMed ID: 22917970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct residues of human p53 implicated in binding to DNA, simian virus 40 large T antigen, 53BP1, and 53BP2.
    Thukral SK; Blain GC; Chang KK; Fields S
    Mol Cell Biol; 1994 Dec; 14(12):8315-21. PubMed ID: 7969167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.
    Suad O; Rozenberg H; Brosh R; Diskin-Posner Y; Kessler N; Shimon LJ; Frolow F; Liran A; Rotter V; Shakked Z
    J Mol Biol; 2009 Jan; 385(1):249-65. PubMed ID: 18996393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structure of the mouse p53 core DNA-binding domain at 2.7 A resolution.
    Zhao K; Chai X; Johnston K; Clements A; Marmorstein R
    J Biol Chem; 2001 Apr; 276(15):12120-7. PubMed ID: 11152481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of Rad51 and other peptide sequences to a promiscuous, highly electrostatic binding site in p53.
    Friedler A; Veprintsev DB; Rutherford T; von Glos KI; Fersht AR
    J Biol Chem; 2005 Mar; 280(9):8051-9. PubMed ID: 15611070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of p53-mediated transcriptional activation by the p53-binding proteins, 53BP1 and 53BP2.
    Iwabuchi K; Li B; Massa HF; Trask BJ; Date T; Fields S
    J Biol Chem; 1998 Oct; 273(40):26061-8. PubMed ID: 9748285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structure of the ARF-GAP domain and ankyrin repeats of PYK2-associated protein beta.
    Mandiyan V; Andreev J; Schlessinger J; Hubbard SR
    EMBO J; 1999 Dec; 18(24):6890-8. PubMed ID: 10601011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The structure and interactions of the proline-rich domain of ASPP2.
    Rotem S; Katz C; Benyamini H; Lebendiker M; Veprintsev D; Rüdiger S; Danieli T; Friedler A
    J Biol Chem; 2008 Jul; 283(27):18990-9. PubMed ID: 18448430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.